Search Results - Rayven Frierson
- Showing 1 - 1 results of 1
-
1
An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity by Isabel H. Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A. Reyes Curcio, Andres E. Franceschi, Chloe Lahoud, Dimitrios G. Moshovitis, Katherine Beluch, Manu Balusu, C. Elizabeth Keleher, Keri M. Sullivan, Michael Dougan, Qianwen Wang, Jennifer H. Han, Ahmed Nader, Alicia Aylott, Wei Wang, Brian T. Chan, Sarah P. Hammond, Jennifer Manne-Goehler, Sophia Koo
Published in New Microbes and New Infections (2025-10-01)Get full text
Article
